ICU Medical Syringe Transfer Set w/MicroClave, ChemoLock Port REF: CL-34 Recall
ICU Medical Syringe Transfer Set w/MicroClave, ChemoLock Port REF: CL-34
FDA recall Class II
Ongoing
FDA lists this Class II recall for ICU Medical Syringe Transfer Set w/MicroClave, ChemoLock Port REF: CL-34. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0356-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Sep 8, 2025
- FDA report date
- Nov 5, 2025
- Quantity in commerce
- 900 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
ICU Medical Syringe Transfer Set w/MicroClave, ChemoLock Port REF: CL-34
Affected model & UDI checker
Search the exact identifiers published for Z-0356-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| CL-34 | ICU Medical Syringe Transfer Set w/MicroClave, ChemoLock Port REF: CL-34 | Check source notice | Not specified |
FDA code information
Lot:14400199; Distributed in Canada
Why was this product recalled?
Port weld of drug transfer device may separate or break during use and potentially result in a leak.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Icu Medical, Inc. take?
On September 8, 2025, ICU Medical issued an "Urgent Medical Device" Recall notification via E-Mail. ICU Medical ask consignees to take the following actions: 1. Check all inventory locations within your institution for the affected products listed in recall notification and discontinue use. Destroy all affected products following your institution's process for destruction. If destroying is not immediately possible at your facility, then the product should be quarantined until disposal. 2. Share this notification with all potential users of the device, to ensure they are aware of this notification. If the devices are used at another location, please ensure this communication is delivered there. 3. Complete and return the attached Customer Response Form to marketaction@mailac.custhelp.com within 10 days of receipt to acknowledge your understanding of this notification. 4. If you have distributed affected products to your customers, please immediately forward this notice to them. Request that they complete the response form and return it to marketaction@mailac.custhelp.com For further inquiries, please contact ICU Medical Customer Service via email: customerservice@icumed.com or call: 1-(800)-258-5361 for additional information or technical assistance. Or contact Field Service Processing via email: marketaction@mailac.custhelp.com for Assistance with Customer Notifications and Response Forms.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0356-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology